Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
4.560
-0.110 (-2.36%)
At close: May 14, 2025, 4:00 PM
4.560
0.00 (0.00%)
After-hours: May 14, 2025, 4:36 PM EDT
Bausch Health Companies Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Bausch Health Companies stock ranges from a low of $3.00 to a high of $10. The average analyst price target of $7.20 forecasts a 57.89% increase in the stock price over the next year.
Price Target: $7.20 (+57.89%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Bausch Health Companies stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $8.5 → $10 | Hold | Maintains | $8.5 → $10 | +119.30% | May 2, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $12 → $8 | Strong Buy → Hold | Downgrades | $12 → $8 | +75.44% | Feb 6, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +119.30% | Jan 30, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +141.23% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $8.5 | Hold | Maintains | $10 → $8.5 | +86.40% | Aug 2, 2024 |
Financial Forecast
Revenue This Year
10.10B
from 9.63B
Increased by 4.92%
Revenue Next Year
10.34B
from 10.10B
Increased by 2.36%
EPS This Year
4.54
from -0.13
EPS Next Year
4.65
from 4.54
Increased by 2.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5B | 10.9B | 11.3B | ||
| Avg | 10.1B | 10.3B | 10.7B | ||
| Low | 9.8B | 9.7B | 10.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.6% | 8.3% | 9.7% | ||
| Avg | 4.9% | 2.4% | 3.6% | ||
| Low | 1.4% | -4.3% | -2.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.95 | 5.30 | 6.26 | ||
| Avg | 4.54 | 4.65 | 5.79 | ||
| Low | 3.98 | 3.72 | 5.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 16.7% | 34.6% | ||
| Avg | - | 2.5% | 24.4% | ||
| Low | - | -18.0% | 15.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.